Skip to content
Lower risk Drug recall · FDA · Published August 19, 2021

Rhodes Pharmaceuticals recalls 10mg Oxycodone tablets with foreign medication

Rhodes Pharmaceuticals recalls 10mg Oxycodone tablets due to foreign hydrochlorothiazide/lisinopril tablets found in one batch. Consumers should check their bottles for the specific lot number and contact the company for details.

🇺🇸 FDA recall #D-0794-2021DrugRhodes Pharmaceuticals ›
Take action

Contact the company

Recalling firmRhodes Pharmaceuticals, L.P.498 Washington St · Coventry, RI 02816-5467
✎ GovInfoNow plain-language explainer

Rhodes Pharmaceuticals is recalling 10mg Oxycodone Hydrochloride Tablets because a single foreign tablet containing hydrochlorothiazide and lisinopril was found in one bottle. This could pose a risk if someone takes the foreign medication without knowing it. Read more at govinfonow.com/recall/35930-rhodes-pharmaceuticals-recalls-10mg-oxycodone-tablets-with-foreign-medication.

Source Summary by GovInfoNow · govinfonow.com/recall/35930-rhodes-pharmaceuticals-recalls-10mg-oxycodone-tablets-with-foreign-medication · Updated August 18, 2026 · FDA enforcement record: FDA #D-0794-2021

Cite this page

“Rhodes Pharmaceuticals recalls 10mg Oxycodone tablets with foreign medication.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35930-rhodes-pharmaceuticals-recalls-10mg-oxycodone-tablets-with-foreign-medication. Based on FDA recall #D-0794-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0794-2021%22&limit=1).

The FDA announced on Aug. 19, 2021, that Rhodes Pharmaceuticals L.P. is recalling Oxycodone Hydrochloride Tablets USP, 10 mg, due to the presence of foreign tablets. The agency said a single bottle contained a Hydrochlorothiazide/Lisinopril tablet.

How to tell if you have it

  • Brand: Rhodes Pharmaceuticals
  • Product: Oxycodone Hydrochloride Tablets, USP, 10 mg, 100 count bottle
  • NDC: 42858-002-01
  • Lot #: WP5K0Y
  • Expiration date: 02/28/2023
  • Quantity: 55,344 bottles
  • Distribution: Nationwide

The hazard

The recall is due to the presence of foreign tablets in one bottle. The FDA said a single Hydrochlorothiazide/Lisinopril 25/20 tablet was found in one bottle of Oxycodone Hydrochloride Tablets.

Context

GovInfoNow's records show Rhodes Pharmaceuticals, L.P. has one other recall on record since April 17, 2018, for Aptensio XR capsules regarding failed dissolution specifications. Other recent recalls of similar products include Glenmark Bisoprolol/Hydrochlorothiazide Tablets Recall (Nov. 21, 2025), Granules Pharmaceuticals Trazodone 50mg Recall (Jan. 26, 2026), and Amerisource Health Primidone Tablets Recall (May 1, 2026).

How to tell if you have this one

Check your Oxycodone Hydrochloride Tablets, USP, 10mg, 100-count bottle for the lot number WP5K0Y and expiration date 02/28/2023. The product is only available by prescription.

  • Brand
    Rhodes Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Product

    Look for the lot number WP5K0Y and expiration date 02/28/2023 on the bottle.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Product was distributed nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 19 months after the firm started it.

1. Firm started the recall: Aug 19, 202112. FDA classified it Class II: Sep 13, 202123. Published in FDA’s Enforcement Report: Sep 22, 202134. FDA terminated the recall: Mar 7, 2023420212023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0794-2021 (August 19, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0794-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA